Literature DB >> 32725198

Effects of chronic exposure to low doses of Δ9- tetrahydrocannabinol in adolescence and adulthood on serotonin/norepinephrine neurotransmission and emotional behaviors.

Danilo De Gregorio1, Joshua Dean Conway2, Martha-Lopez Canul1, Luca Posa1, Francis Rodriguez Bambico2,3, Gabriella Gobbi1.   

Abstract

BACKGROUND: Chronic exposure to the Δ9-tetrahydrocannabinol (THC), the main cannabis pharmacological component, during adolescence has been shown to be associated with an increased risk of depression and suicidality in humans. AIMS: Little is known about the impact of the long-term effects of chronic exposure to low doses of THC in adolescent compared to adult rodents.
METHODS: THC (1mg/kg i.p., once a day) or vehicle was administered for 20 days in both adolescent (post-natal day, PND 30-50) and young adult rats (PND 50-70). After a long washout period (20 days), several behavioral paradigms and electrophysiological recordings of serotonin (5-HT) and norepinephrine (NE) neurons were carried out.
RESULTS: Adolescent THC exposure resulted in depressive lbehaviors: a significant decrease in latency to first immobility in the forced swim test, increased anhedonia in the sucrose preference test. Decrease entries in the open arm were observed in the elevated plus maze after adolescent and adult exposure, indicating anxiousphenotype. A significant reduction in dorsal raphe serotonergic neural activity without changing locus coeruleus noradrenergic neural activity was found in THC adolescent and adult exposure.
CONCLUSIONS: Altogether, these findings suggest that low doses of chronic THC exposure during the developmental period and adulthood could result in increased vulnerability of the 5-HT system and anxiety symptoms; however, depressive phenotypes occur only after adolescent, but not adult exposure, underscoring the higher vulnerability of young ages to the mental effects of cannabis.
© The Author(s) 2020. Published by Oxford University Press on behalf of CINP.

Entities:  

Keywords:  CB1 receptor; adolescents; anxiety; cannabinoids; depression; monoamine; reward

Year:  2020        PMID: 32725198     DOI: 10.1093/ijnp/pyaa058

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  3 in total

Review 1.  Associations between cannabis use, cannabis use disorder, and mood disorders: longitudinal, genetic, and neurocognitive evidence.

Authors:  Lauren Kuhns; Emese Kroon; Karis Colyer-Patel; Janna Cousijn
Journal:  Psychopharmacology (Berl)       Date:  2021-11-06       Impact factor: 4.415

2.  Editorial: The Endocannabinoid System: Filling the Translational Gap Between Neuroscience and Psychiatry.

Authors:  Danilo De Gregorio; Mirella Ruggeri; Sagnik Bhattacharyya; Marco Colizzi
Journal:  Front Psychiatry       Date:  2021-10-28       Impact factor: 4.157

Review 3.  Molecular Targets of Cannabinoids Associated with Depression.

Authors:  Pradeep Paudel; Samir Ross; Xing-Cong Li
Journal:  Curr Med Chem       Date:  2022       Impact factor: 4.740

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.